Risk assessment in correlation with obesity and laboratory monitoring of the most common female breast cancers in Sarajevo Canton

Author:

Kustura AmarORCID,Hasanefendić Berina,Halilović Lajla,Ibričević Balić,Suljić Muamer,Smailbegović Velda

Abstract

Abstract: Introduction: Breast cancer (BC) is a malignant disease that predominantly affects women, with known genetic components such as mutations in tumor suppressor genes BRCA1 and BRCA2. Other risk factors include unhealthy lifestyles, lack of physical activity, and consumption of alcohol and cigarettes. Aging also plays a role in BC development, with hormonal influences such as estrogen and progesterone promoting cancer growth. Material and Methods: Research was conducted using data collection tools for risk factors and tumor markers from primary healthcare unit records. The sample comprised 200 women, divided into two groups based on BC diagnosis, with complete medical documentation. Male BC cases were excluded. Results: Statistical significance was found between genetic components, family history, aging, obesity, alcohol and cigarette consumption, longer hormone exposure, and female BC development using the Chi-Square test, confirmed by Fisher's Exact test. Tumor markers CA 15-3, CEA, CA 19-9, and CA 125 were useful for BC screening and metastasis detection, as determined by the One Sample T-test. In Sarajevo Canton, invasive ductal BC was the most common type among women, while lobular carcinoma in situ was the least common. Conclusion: Correlations between risk factors, including aging, unhealthy lifestyles, and hormone exposure, and increased BC risk were confirmed. Tumor markers CA 15-3, CEA, CA 19-9, and CA 125 were effective in diagnosis, screening, and metastasis detection in females, with sensitivity for regression detection at 81.8% and specificity at 100%.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Reference12 articles.

1. World Health Organisation. Breast cancer. WHO.int. 2023. URL: https://www.who.int/news-room/fact-sheets/detail/ breast-cancer (01/20/2024);

2. Zavod za javno zdravstvo FBiH. Mjesec borbe protiv raka dojke -ZZJZ FBiH. 2023. URL: https://www.zzjzfbih.ba/ mjesec-borbe-protiv-raka-dojke/ (01/20/2024);

3. Cancer Expert Working Group on Cancer Prevention and Screening. Recommendations on Prevention and Screening for breast cancer. https://www.chp.gov.hk/files/pdf/breast_cancer_professional_hp.pdf;

4. Grgić K. Povezanost samoprocjena rizika obolijevanja od raka dojke i stavova o primarnoj kemoprevenciji raka dojke u populaciji žena bez raka dojke [Diplomski rad]. Osijek: Sveučilište Josipa Jurja Strossmayera u Osijeku, Medicinski fakultet Osijek; 2019. Available on: https://urn.nsk.hr/ urn:nbn:hr:152:758586;

5. Hing JX, Mok CW, Tan PT, Sudhakar SS, Seah CM, Lee WP et al. Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance. Breast. 2020; 52: 95-101. doi: 10.1016/j.breast.2020.05.005;

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3